4.7 Editorial Material

Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann et al.

Summary: The discipline of Cardio-Oncology focuses on the cardiovascular care of cancer patients and the management of cardiovascular complications of cancer therapies. This document provides consensus definitions for common cardiovascular toxicities and aims to improve communication and outcomes in clinical practice and research.

EUROPEAN HEART JOURNAL (2022)

Letter Cardiac & Cardiovascular Systems

Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis

Vasiliki Tsampasian et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Article Oncology

Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors

Kerryn W. Reding et al.

Summary: Breast cancer survivors, especially postmenopausal ones, have a higher incidence of heart failure, particularly HFpEF. This study aims to estimate the incidence of HFpEF and HFrEF in postmenopausal BC survivors and identify the associated risk factors.

JACC: CARDIOONCOLOGY (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Editorial Material Cardiac & Cardiovascular Systems

The Universal Definition of Heart Failure: Perspectives from Diverse Stakeholders

Robert J. Mentz et al.

JOURNAL OF CARDIAC FAILURE (2021)

Article Medicine, General & Internal

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Stefan D. Anker et al.

Summary: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

S. D. Solomon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient

Juan Carlos Plana et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Review Cardiac & Cardiovascular Systems

Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction

Ambarish Pandey et al.

JACC-HEART FAILURE (2018)

Article Oncology

Heart Failure and Long-Term Survival Among Older Women With Breast Cancer

Jordan M. Harrison et al.

ONCOLOGY NURSING FORUM (2018)

Article Cardiac & Cardiovascular Systems

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes

Kevin S. Shah et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure

Ambarish Pandey et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer

Husam Abdel-Qadir et al.

JAMA CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction A Multiorgan Roadmap

Sanjiv J. Shah et al.

CIRCULATION (2016)

Review Medicine, Research & Experimental

Pathophysiology of exercise intolerance in breast cancer survivors with preserved left ventricular ejection fraction

Mark J. Haykowsky et al.

CLINICAL SCIENCE (2016)

Article Public, Environmental & Occupational Health

Cardiovascular Disease Mortality Among Breast Cancer Survivors

Patrick T. Bradshaw et al.

EPIDEMIOLOGY (2016)

Editorial Material Cardiac & Cardiovascular Systems

The HFpEF Obesity Phenotype The Elephant in the Room

Dalane W. Kitzman et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance

Sujethra Vasu et al.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2013)

Article Oncology

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

Erin J. Aiello Bowles et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Article Cardiac & Cardiovascular Systems

Early breast cancer therapy and cardiovascular injury

Lee W. Jones et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry

Gregg C. Fonarow et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)